8-K current report · filed Sep 14, 2026

Teva Pharmaceutical Industries Ltd (TEVA) 8-K Current Report: September 14, 2026

Item 8.01TEVA overview

Short answer

Teva Pharmaceutical Industries Ltd (TEVA) filed an 8-K current report with the SEC on September 14, 2026 reporting Item 8.01 (Other Events). NYSE trading shifted from ADSs to ordinary shares under ticker TEVA on September 14, 2026.

Teva Pharmaceutical Industries Ltd 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • NYSE trading shifted from ADSs to ordinary shares under ticker TEVA on September 14, 2026
  • ADS program terminated, with each ADS exchanged one-for-one into an ordinary share
  • Tel Aviv Stock Exchange listing continues under TEVA
  • Investors retain U.S. market access, while the security structure and ADS-related administration change

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Teva Pharmaceutical Industries Ltd 8-K filings

Get the next TEVA 8-K as it lands

Follow TEVA for push alerts, or ask the research agent what this filing means.